Environmental

DRMA appears broadly in line with smaller healthcare peers on direct environmental exposure, as the business model is typically less emissions-intensive than industrial or chemical comparables.

The absence of disclosed R&D intensity in the provided metrics limits evidence of product-design environmental differentiation versus peers, keeping the environmental profile neutral rather than advantaged.

No provided data indicate material climate, waste, or resource-management liabilities, which reduces near-term regulatory risk relative to more resource-intensive peers.

Environmental positioning is constrained by limited disclosure in the supplied dataset, so the company cannot be assessed as clearly stronger than peers on measurable environmental execution.

Social

DRMA’s social profile is likely shaped by healthcare-related stakeholder expectations, where product quality and patient safety matter more than in non-regulated sectors.

The provided metrics show no stock-based compensation burden, which can modestly support workforce alignment versus peers that rely more heavily on equity incentives.

Limited disclosure on employee, customer, and community metrics prevents evidence of a peer-leading social record, keeping the assessment at a middle level.

Without reported controversies or adverse social indicators in the supplied data, DRMA does not appear structurally weaker than peers on social risk.

Governance

DRMA’s zero debt-to-equity ratio suggests a conservative capital structure, which can reduce governance pressure from creditor oversight versus more leveraged peers.

Net debt to EBITDA of 0.52x indicates modest leverage, supporting financial discipline relative to peers with heavier balance-sheet risk.

The absence of disclosed SBC burden in the provided metrics is a positive governance signal, because it limits dilution concerns versus equity-heavy peers.

However, the dataset provides no board, audit, ownership, or controversy evidence, so governance cannot be rated above a moderate peer-relative level.

Overall Score

DRMA screens as a middle-tier ESG name versus peers because modest leverage and limited negative indicators are offset by sparse disclosure and no clear structural advantage.

Score Driver: Limited ESG Disclosure Prevents Evidence Of A Sustained Peer-Leading Advantage Across Environmental, Social, Or Governance Dimensions.